How To Be A Dynamic Model

Princeton, NJ – Every year, news broadcasts detail reports about communicable diseases in our country. How do disease-control organizations make decisions about how to effectively treat these diseases? Most likely, they analyze the options using dynamic models.

“A dynamic model is needed when evaluating an intervention against an infectious disease that 1) has an impact on disease transmission in the target population, or 2) alters the frequency distribution of strains (e.g., genotypes or serotypes),” says Dr. Richard Pitman, PhD, lead author on the paper, “Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5 .” Best practices for designing dynamic transmission modeling studies are presented in this paper.

This paper is one of the seven papers in the series on modeling study best practices and is jointly published in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and Medical Decision Making, the official journal of the Society for Medical Decision Making (SMDM).


Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Posted in Value in Health Tagged with: , , ,